Template:Bedaquiline: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Bedaquiline|{{fontcolor|#6C7B8B|Bedaquiline}}]]''''' | |||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background: | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | SIRTURO<sup>®</sup> FDA Package Insert | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline description|Description]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline description|Description]] | ||
| Line 21: | Line 21: | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline dosage and administration|Dosage and Administration]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline dosage and administration|Dosage and Administration]] | ||
| | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline how supplied|How Supplied]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Bedaquiline labels and packages|Labels and Packages]] | ||
|- | |- | ||
|} | |} | ||